Evidence-based guides on hair loss stages, treatment options, transplant procedures, and recovery.
Fertility treatments including IVF and Clomid affect hormone levels and can trigger hair loss. myhairline.ai tracks density alongside fertility treatment cycles to document any impact.
FGF5 inhibitors extend the anagen growth phase by blocking the signal that triggers the transition to catagen. myhairline.ai tracks density response to FGF5-inhibiting ingredients.
Scalp fibrosis accompanies lichen planopilaris, FFA, and CCCA. myhairline.ai tracks the fibrosis boundary progression alongside density loss to document the extent and progression rate.
1mg and 5mg Finasteride produce similar DHT reduction (70% vs 73%), but some patients report better density at higher doses. Compare tracking data for both.
Understanding why 5-alpha reductase inhibitors work helps you interpret your density data. This guide explains the mechanism and how tracking confirms whether inhibition is working for you.
Finasteride regrowth can be terminal or vellus. myhairline.ai estimates regrowth type from AI shaft diameter analysis to help you understand the quality of your hair recovery.
Androgenetic alopecia resumes at the pre-treatment rate within 6-12 months of stopping Finasteride. Track the decline and decide whether to restart with data.
Finasteride is widely prescribed in India under multiple brand names including Finpecia. myhairline.ai tracks results for Indian patients with dermatologist-report export for Indian clinic formats.
Sexual side effects are the main concern for Finasteride users. myhairline.ai lets you log libido and sexual health indicators alongside density to make an informed risk-benefit decision.
Most Finasteride studies run 5 years. This guide uses long-term tracking data to show what density typically looks like at 5 years and beyond on continuous Finasteride therapy.
Some Finasteride users report mood changes and depression. myhairline.ai allows mood logging alongside density data to create a comprehensive risk-benefit record for prescriber review.
Approximately 17% of men do not respond to Finasteride. myhairline.ai tracks density response and identifies non-responders at 6-9 months so they can pivot to Dutasteride or other treatments.